Stay updated with breaking news from Director Garry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) shares fell 3.8% during mid-day trading on Monday . The stock traded as low as $0.72 and last traded at $0.75. 97,194 shares changed hands during trading, a decline of 86% from the average session volume of 684,853 shares. The stock had previously closed at $0.78. Analyst […]
Shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy […]
Shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw strong trading volume on Tuesday . 903,919 shares were traded during trading, an increase of 30% from the previous session’s volume of 693,591 shares.The stock last traded at $0.70 and had previously closed at $0.74. Analyst Upgrades and Downgrades Several equities analysts have recently […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $0.80, but opened at $0.83. Adaptimmune Therapeutics shares last traded at $0.79, with a volume of 7,753 shares changing hands. Wall Street Analysts Forecast Growth ADAP has been the subject of several […]
Long Focus Capital Management LLC lessened its stake in Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) by 47.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,772,791 shares of the biotechnology company’s stock after selling 2,510,848 shares during the quarter. […]